|Expected size of offer (M):||NIL|
|Expected first date of trading:||03/06/2014|
|Location of address at which admission document will be available:||www.biofrontera.com/en/investors The Admission Document will contain full details about the Company and the admission of its securities.|
|Date at which admission document will be available:||-|
|Nominated Advisor (AIM Companies):||finnCap Ltd|
|Nominated Broker (AIM Companies):||finnCap Ltd|
|Hermann Luebbert, PhD||Chairman of the Management Board and Chief Executive Officer|
|Thomas Schaffer||Member of the Management Board and Chief Financial Officer|
|Jürgen Baumann||Chairman of the Supervisory Board|
|Andreas Fritsch||Member of the Supervisory Board|
|Dr. Ulrich Granzer||Member of the Supervisory Board|
|Ulrike Kluge||Member of the Supervisory Board|
|Alfred Neimke||Member of the Supervisory Board|
|Prof. Dr. rer. nat. Bernd Wetzel||Vice Chairman of the Supervisory Board|
|Fiscal year end:||31 December|
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
You will be redirected in five seconds